Bittencourt Ize de Aguiar, Serpeloni Mariana, Hiraiwa Priscila Mazzochi, de Arruda Campos Brasil de Souza Tatiana, Ávila Andréa Rodrigues
Instituto Carlos Chagas, Fiocruz Paraná, Brazil.
Instituto Carlos Chagas, Fiocruz Paraná, Brazil.
Int J Biol Macromol. 2017 May;98:793-801. doi: 10.1016/j.ijbiomac.2017.02.050. Epub 2017 Feb 14.
The RNA helicase DEAD-box protein Sub2 (yeast)/UAP56 (mammals) is conserved across eukaryotes and is essential for mRNA export in trypanosomes. Despite the high conservation of Sub2 in lower eukaryotes such as Trypanosoma cruzi, the low conservation of other mRNA export factors raises questions regarding whether the mode of action of TcSub2 is similar to that of orthologs from other eukaryotes. Mutation of the conserved K87 residue of TcSub2 abolishes ATPase activity, showing that its ATPase domain is functional. However, the Vmax of TcSub2 was much higher than the Vmax described for the human protein UAP56, which suggests that the TcSub2 enzyme hydrolyzes ATP faster than its human homolog. Furthermore, we demonstrate that RNA association is less important to the activity of TcSub2 compared to UAP56. Our results show differences in activity of this protein, even though the structure of TcSub2 is very similar to UAP56. Functional complementation assays indicate that these differences may be common to other trypanosomatids. Distinct features of RNA influence and ATPase efficiency between UAP56 and TcSub2 may reflect distinct structures for functional sites of TcSub2. For this reason, ligand-based or structure-based methodologies can be applied to investigate the potential of TcSub2 as a target for new drugs.
RNA解旋酶DEAD盒蛋白Sub2(酵母)/UAP56(哺乳动物)在真核生物中保守,对锥虫的mRNA输出至关重要。尽管在诸如克氏锥虫等低等真核生物中Sub2高度保守,但其他mRNA输出因子的低保守性引发了关于TcSub2的作用模式是否与其他真核生物的直系同源物相似的问题。TcSub2保守的K87残基突变消除了ATP酶活性,表明其ATP酶结构域具有功能。然而,TcSub2的Vmax远高于人类蛋白UAP56的Vmax,这表明TcSub2酶水解ATP的速度比其人类同源物快。此外,我们证明与UAP56相比,RNA结合对TcSub2活性的重要性较低。我们的结果表明,尽管TcSub2的结构与UAP56非常相似,但该蛋白的活性存在差异。功能互补分析表明,这些差异可能在其他锥虫中普遍存在。UAP56和TcSub2之间RNA影响和ATP酶效率的不同特征可能反映了TcSub2功能位点的不同结构。因此,基于配体或基于结构的方法可用于研究TcSub2作为新药靶点的潜力。